BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29022501)

  • 1. Nanotechnology in Personalized Medicine: A Promising Tool for Alzheimer's Disease Treatment.
    De Matteis L; Martín-Rapún R; de la Fuente JM
    Curr Med Chem; 2018; 25(35):4602-4615. PubMed ID: 29022501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology and Alzheimer's disease: what has been done and what to do.
    Ruozi B; Belletti D; Pederzoli F; Veratti P; Forni F; Vandelli MA; Tosi G
    Curr Med Chem; 2014; 21(36):4169-85. PubMed ID: 25039777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine for the treatment of Alzheimer's disease.
    Gregori M; Masserini M; Mancini S
    Nanomedicine (Lond); 2015; 10(7):1203-18. PubMed ID: 25929574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential use of H102 peptide-loaded dual-functional nanoparticles in the treatment of Alzheimer's disease.
    Zhang C; Zheng X; Wan X; Shao X; Liu Q; Zhang Z; Zhang Q
    J Control Release; 2014 Oct; 192():317-24. PubMed ID: 25102404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging nanotechnology for Alzheimer's disease: From detection to treatment.
    Song N; Sun S; Chen K; Wang Y; Wang H; Meng J; Guo M; Zhang XD; Zhang R
    J Control Release; 2023 Aug; 360():392-417. PubMed ID: 37414222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bionanotechnologies for treatment and diagnosis of Alzheimer's disease.
    Moghimi SM
    Nanomedicine; 2011 Oct; 7(5):515-8. PubMed ID: 21616169
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluorinated Molecules and Nanotechnology: Future 'Avengers' against the Alzheimer's Disease?
    Dabur M; Loureiro JA; Pereira MC
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology in the diagnostic and therapy for Alzheimer's disease.
    Panghal A; Flora SJS
    Biochim Biophys Acta Gen Subj; 2024 Mar; 1868(3):130559. PubMed ID: 38191034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers and Precision Medicine in Alzheimer's Disease.
    Sagar R; Pathak P; Pandur B; Kim SJ; Li J; Mahairaki V
    Adv Exp Med Biol; 2021; 1339():403-408. PubMed ID: 35023132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective.
    Ahmad J; Akhter S; Rizwanullah M; Khan MA; Pigeon L; Addo RT; Greig NH; Midoux P; Pichon C; Kamal MA
    Curr Alzheimer Res; 2017; 14(11):1164-1181. PubMed ID: 28482786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized medicine in Alzheimer's disease and depression.
    Souslova T; Marple TC; Spiekerman AM; Mohammad AA
    Contemp Clin Trials; 2013 Nov; 36(2):616-23. PubMed ID: 23816492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Nanoparticles for the Treatment of Alzheimer's Disease.
    Martín-Rapun R; De Matteis L; Ambrosone A; Garcia-Embid S; Gutierrez L; de la Fuente JM
    Curr Pharm Des; 2017; 23(13):1927-1952. PubMed ID: 28025949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-functional nanoparticles for precise drug delivery to Alzheimer's disease lesions: Targeting mechanisms, pharmacodynamics and safety.
    Zheng X; Zhang C; Guo Q; Wan X; Shao X; Liu Q; Zhang Q
    Int J Pharm; 2017 Jun; 525(1):237-248. PubMed ID: 28432017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's Disease Targeted Nano-Based Drug Delivery Systems.
    Altinoglu G; Adali T
    Curr Drug Targets; 2020; 21(7):628-646. PubMed ID: 31744447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology for Alzheimer Disease.
    Leszek J; Md Ashraf G; Tse WH; Zhang J; Gasiorowski K; Avila-Rodriguez MF; Tarasov VV; Barreto GE; Klochkov SG; Bachurin SO; Aliev G
    Curr Alzheimer Res; 2017; 14(11):1182-1189. PubMed ID: 28164767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of multifunctional nanomaterials in Alzheimer's disease: A potential theranostics strategy.
    Xu Y; Zhao M; Zhou D; Zheng T; Zhang H
    Biomed Pharmacother; 2021 May; 137():111360. PubMed ID: 33582451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine Strategies for Sustained, Controlled and Targeted Treatment of Alzheimer's Disease.
    Ma TJ; Gao J; Liu Y; Zhuang JH; Yin C; Li P; Mao L; Xu J; Xu YX; Li YP; Zhao ZX; Yin Y
    Mini Rev Med Chem; 2018; 18(12):1035-1046. PubMed ID: 29243575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment.
    Gauthier S; Ng KP; Pascoal TA; Zhang H; Rosa-Neto P
    J Alzheimers Dis; 2018; 64(s1):S23-S31. PubMed ID: 29504543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer's disease mice.
    Liu Y; An S; Li J; Kuang Y; He X; Guo Y; Ma H; Zhang Y; Ji B; Jiang C
    Biomaterials; 2016 Feb; 80():33-45. PubMed ID: 26706474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection and personalized medicine: Future strategies against Alzheimer's disease.
    Di Meco A; Vassar R
    Prog Mol Biol Transl Sci; 2021; 177():157-173. PubMed ID: 33453940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.